NCT05607550 · Interventional trial
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)
Overall registry status Active not recruiting
Phase 3
Conditions Advanced Non-Small Cell Lung Cancer, EGFR Exon 20 Mutations, Metastatic Non-Small Cell Lung Cancer
Delaware Valley sites
- ArriVent Investigative Site · Langhorne, PA · Bucks County
First posted
Registry updated
Added to the directory